UK Markets open in 2 hrs 58 mins

Innate Pharma S.A. (0EVI.L)

YHD - YHD Delayed price. Currency in USD
Add to watchlist
93,952,000.00+2.62 (+0.00%)
At close: 06:07PM EDT
Full screen
Previous closeN/A
YTD returnN/A
Expense ratio (net)N/A
CategoryN/A
Last cap gainN/A
Morningstar ratingN/A
Morningstar risk ratingN/A
Sustainability ratingN/A
Net assetsN/A
Beta (5Y monthly)N/A
YieldN/A
5y average returnN/A
Holdings turnoverN/A
Last dividendN/A
Average for categoryN/A
Inception dateN/A
  • Business Wire

    Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update

    MARSEILLE, France, March 23, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results1 for the year ending December 31, 2022. The consolidated financial statements are attached to this press release.

  • Business Wire

    Number of Shares and Voting Rights of Innate Pharma as of March 1, 2023

    MARSEILLE, France, March 20, 2023--Pursuant to the article L. 233-8 II of the French "Code de Commerce" and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") releases its total number of shares outstanding as well as its voting rights as at March 1, 2023:

  • Business Wire

    Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results

    MARSEILLE, France, March 16, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Thursday, March 23, 2023 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2022.